Cargando…
Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: II. DNA damage, repair and chromatin changes.
We have reported in the preceding paper that the treatment of plateau phase mouse EMT6 tumour cells with a combination of hyperthermia (HT; 44 degrees C) and trifluoperazine (TFP; 30 micrograms ml-1; an inhibitor of calmodulin) greatly enhances the cytotoxicity of the antitumour drug belomycin (BLM)...
Autores principales: | Smith, P. J., Mircheva, J., Bleehen, N. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001464/ https://www.ncbi.nlm.nih.gov/pubmed/2418859 |
Ejemplares similares
-
Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: I. In vitro cytotoxicity.
por: Mircheva, J., et al.
Publicado: (1986) -
Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
por: Kamath, N., et al.
Publicado: (1993) -
Trifluoperazine, a calmodulin antagonist, inhibits muscle cell fusion
Publicado: (1983) -
Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo.
por: Twentyman, P. R., et al.
Publicado: (1975) -
The sensitivity to bleomycin of a solid mouse tumour at different stages of growth.
por: Twentyman, P. R., et al.
Publicado: (1974)